A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS
Clinical trial NCT04623996 · TERMINATED
Trial details
- NCT number
- NCT04623996
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-28
- Primary completion
- 2021-04-27
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.